Posted On: 09/20/2016 5:08:58 PM
Post# of 72447
CELLCEUTIX CORPORATION (OTCMKTS:CTIX) Sellers Covered 11.7% of Their Shorts
The stock of CELLCEUTIX CORPORATION (OTCMKTS:CTIX) registered a decrease of 11.7% in short interest. CTIX’s total short interest was 726,000 shares in September as published by FINRA. Its down 11.7% from 822,200 shares, reported previously. With 259,800 shares average volume, it will take short sellers 3 days to cover their CTIX’s short positions. The stock increased 0.76% or $0.01 during the last trading session, hitting $1.32. About 118,733 shares traded hands. Cellceutix Corp (OTCMKTS:CTIX) has risen 18.92% since February 12, 2016 and is uptrending. It has outperformed by 4.21% the S&P500.
Cellceutix Corporation is a clinical-stage pharmaceutical company. The company has a market cap of $158.21 million. The Firm is focused on developing and/or acquiring small molecule therapies. It currently has negative earnings. The Company’s clinical programs include Kevetrin, Prurisol, Brilacidin and Brilacidin-OM.
http://www.kentuckypostnews.com/cellceutix-co...ts/165611/
The stock of CELLCEUTIX CORPORATION (OTCMKTS:CTIX) registered a decrease of 11.7% in short interest. CTIX’s total short interest was 726,000 shares in September as published by FINRA. Its down 11.7% from 822,200 shares, reported previously. With 259,800 shares average volume, it will take short sellers 3 days to cover their CTIX’s short positions. The stock increased 0.76% or $0.01 during the last trading session, hitting $1.32. About 118,733 shares traded hands. Cellceutix Corp (OTCMKTS:CTIX) has risen 18.92% since February 12, 2016 and is uptrending. It has outperformed by 4.21% the S&P500.
Cellceutix Corporation is a clinical-stage pharmaceutical company. The company has a market cap of $158.21 million. The Firm is focused on developing and/or acquiring small molecule therapies. It currently has negative earnings. The Company’s clinical programs include Kevetrin, Prurisol, Brilacidin and Brilacidin-OM.
http://www.kentuckypostnews.com/cellceutix-co...ts/165611/
(2)
(0)
